A rat study in Bioelectromagnetics examined GSM-modulated 3.5 GHz RF-EMF exposure (2 h/day for 30 days) and reported adverse changes in male reproductive hormones, oxidative stress markers, and testicular histology. The authors also tested Coenzyme Q10 (CoQ10) and found it partially ameliorated some RF-associated alterations. The paper notes that because the exposure used a GSM-modulated waveform, findings cannot be extrapolated to FR1 5G NR signals, and calls for further research under real-world conditions.

This RF Safe article reports that in mid-January 2026 HHS, led by Secretary Robert F. Kennedy Jr., removed or redirected certain FDA webpages that previously conveyed strong “no-risk” conclusions about cellphone radiation. It argues the updated FDA framing emphasizes statutory duties (monitoring, testing, hazard control) and signals a shift from definitive safety messaging toward renewed inquiry, while noting that details of any planned research have not been publicly disclosed. The piece also highlights Kennedy’s past public statements alleging harms from Wi‑Fi/5G and links the policy context to the 2021 D.C. Circuit remand of FCC RF policy.

RF Safe argues that “no effect” findings in some RF exposure studies should be interpreted as meaningful negative controls rather than as evidence that RF has no biological effects. The post presents RF Safe’s “S4–Mito–Spin” framework, claiming certain skin cell types (fibroblasts and keratinocytes) are predicted to be relatively resistant to non-thermal RF effects, so null results in these cells can be consistent with the model. It cites in-vitro studies at 3.5 GHz (5G-modulated) reporting no changes in ROS measures, stress responses, or UV-B DNA repair kinetics under specified SAR conditions, and frames these nulls as boundary conditions rather than a general safety conclusion.

This animal study tested whether short-term 28 GHz (5G-band) millimeter-wave exposure modifies doxorubicin-induced cardiotoxicity in male rats and whether vitamin C mitigates effects. Co-exposure to 28 GHz EMR was reported to worsen several indices of DOX-related cardiac injury (including CAT reduction, increased BAX expression, and QT prolongation), while vitamin C provided partial attenuation. The authors emphasize that results are limited to a short-duration preclinical model and that human relevance remains preliminary.

This animal experiment assessed GSM-modulated 3.5 GHz RF exposure in male Wistar rats and reported hormonal, oxidative, and histological changes consistent with testicular impairment. RF exposure was associated with lower testosterone, LH, and FSH, higher oxidative stress (increased MDA and TOS), and degenerative testicular histology. Coenzyme Q10 supplementation partially mitigated several reported changes. The authors caution against generalizing these results to FR1 5G NR signals and call for further research.

RF Safe argues that common marketing claims for anti-radiation phone cases (e.g., “99% shielding”) are misleading because they often rely on controlled lab fabric tests that do not reflect real-world phone use. The post claims factors like shield orientation, phone transmit-power increases under obstruction, frequency differences (including 5G bands), and user/body interactions can reduce or even reverse purported exposure reductions. It also criticizes current regulatory testing frameworks for not requiring phones to be tested with cases and promotes RF Safe’s own “TruthCase/QuantaCase” approach as a more honest alternative.

An RF Safe article argues that “non-thermal” RF/ELF electromagnetic fields from phones, Wi‑Fi, and 5G cause widespread biological harm and that regulators and industry have misled the public by focusing on heating-based safety limits. It claims 2025 is a “tipping point,” citing WHO-commissioned reviews, animal studies (e.g., NTP/Ramazzini), a “Frontiers review,” and ICBE-EMF statements as evidence of cancer and other health risks. The piece frames the issue as urgent and settled, calling for public action and policy change, but presents these conclusions in advocacy language without providing verifiable study details in the excerpt.

An RF Safe commentary advocates for a proposed “Clean Ether Act” that would mandate replacing Wi‑Fi/5G with LiFi, arguing that current RF exposure limits ignore non-thermal biological effects. The post alleges widespread health harms from RF/EMF (e.g., cancers, fertility impacts) and claims regulatory capture by industry, citing animal studies and a U.S. court decision as support. It frames the issue as urgent and preventable through policy changes and technology substitution, but presents these assertions in highly charged language without providing verifiable bill details in the text shown.

This RF Safe commentary argues that non-thermal RF/5G effects may vary by tissue based on the density of specific biological “targets,” such as voltage-gated channel S4 helices, mitochondrial/NOX ROS capacity, and heme/flavin “spin chemistry” substrates. It claims that reported null findings in 5G mmWave skin-cell studies can be reconciled with reported red blood cell (RBC) rouleaux observations by proposing a “density-gated” mechanism where spin-related effects are more detectable in heme-dense cells like RBCs. The post cites an ultrasound study (named “Brown & Biebrich”) as showing in-vivo rouleaux changes within minutes near a smartphone, but provides limited methodological detail in the excerpt.

RF Safe comments on a 2025 PNAS Nexus study (Jyoti et al., 2025) reporting no detectable changes in gene expression or methylation in 5G millimeter-wave–exposed human skin cells. The post argues that this “null” result does not indicate biological inertness, but instead supports the site’s proposed “dual-pillar” framework in which effects depend on cell-specific cofactor density and frequency-window/coupling conditions. It contrasts skin-cell findings with claims about rapid blood (RBC) effects from smartphone exposure, presenting this as consistent with differential susceptibility across tissues.

RF Safe argues that a single biological mechanism explains widespread harm to children from modern wireless signals (cell phones, Wi‑Fi, 5G, DECT), emphasizing that these signals are “pulsed and modulated.” The post claims that “animal proof” is now high-certainty and references “WHO 2025 GRADE-rated systematic reviews,” linking EMF exposure to rare cancers in young people, declining sperm counts, and childhood autoimmune/neurodevelopmental disorders. The excerpt provided does not include citations or details sufficient to verify these claims.

This RF Safe article argues that “non-native” electromagnetic fields (from power systems, radio, and mobile/5G signals) can disrupt the timing of voltage-gated ion channel activity in immune cells, leading to altered immune signaling, mitochondrial stress, and chronic inflammation. It links these proposed mechanisms to increases in autoimmune-type and immune-driven diseases over time, and cites a mix of reviews, cell studies, animal studies, and rodent bioassays as supportive evidence. The piece frames EMF risk as driven by signal timing/patterning rather than heating, and calls for regulation and engineering changes to address these effects.

This animal study examined whether paternal exposure to 4.9 GHz (5G) radiofrequency radiation affects male offspring in C57BL/6 mice. It reports increased anxiety-like behavior and reduced sperm quality in adult F1 males from exposed fathers, alongside reported LRGUK hypermethylation and reduced LRGUK expression in testes. The abstract reports no significant effects on depression-like behavior, learning/memory, or fertility across F1–F2 generations.

This animal study exposed Aedes aegypti larvae to 5G-NR RF-EMF at 3.6 GHz for 5 days under two feeding regimes. The study reports delayed development at a lower exposure level mainly in nutritionally weakened larvae, and at a higher exposure level reports developmental changes and reduced adult size attributed to dielectric heating. Mortality and wing length asymmetry were reported as unchanged, and the authors note such high exposure levels are unlikely in natural aquatic settings.

This animal study used metabolomics to assess metabolic changes in male Drosophila melanogaster exposed to 3.5 GHz RF-EMF at 0.1, 1, and 10 W/m². It reports disruptions in four metabolic pathways and 34 differential metabolites, with significant decreases in several metabolites including GABA, glucose-6-phosphate, and AMP. The authors interpret the findings as suggesting RF-EMF-related metabolic disturbance, while noting no clear dose-dependent pattern.

This numerical study modeled RF exposure from WiFi/5G-type antennas near a 3D brain model with implanted brain pacemakers relevant to Parkinson’s disease. SAR and temperature increases were reported to remain below ICNIRP 2020 limits across modeled conditions, with maxima at a 90° antenna-to-brain angle. Despite compliance with SAR/temperature limits, the authors report modeled thermal strain and tissue displacement that could affect postoperative efficacy, leading them to recommend caution and increased distance from phones.